Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
0.9959
-0.0041 (-0.41%)
At close: Dec 12, 2025, 4:00 PM EST
1.010
+0.014 (1.42%)
Pre-market: Dec 15, 2025, 9:06 AM EST
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $96.77 million as of December 15, 2025. Its market cap has increased by 32.66% in one year.
Market Cap
96.77M
Enterprise Value
75.39M
1-Year Change
32.66%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $96.77M, an increase of 114.83%. That is a compound annual growth rate of 16.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 96.77M | 50.74% |
| Dec 31, 2024 | 64.19M | -19.95% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
| Jan 27, 2021 | 45.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |